| Literature DB >> 27059719 |
Siva Kumar Solleti1, Sorachai Srisuma2, Soumyaroop Bhattacharya1, Javier Rangel-Moreno3, Kaiser M Bijli4, Troy D Randall5, Arshad Rahman1, Thomas J Mariani6.
Abstract
Serine proteinase inhibitor, clade E, member 2 (SERPINE2), is a cell- and extracellular matrix-associated inhibitor of thrombin. Although SERPINE2 is a candidate susceptibility gene for chronic obstructive pulmonary disease, the physiologic role of this protease inhibitor in lung development and homeostasis is unknown. We observed spontaneous monocytic-cell infiltration in the lungs of Serpine2-deficient (SE2(-/-)) mice, beginning at or before the time of lung maturity, which resulted in lesions that resembled bronchus-associated lymphoid tissue (BALT). The initiation of lymphocyte accumulation in the lungs of SE2(-/-) mice involved the excessive expression of chemokines, cytokines, and adhesion molecules that are essential for BALT induction, organization, and maintenance. BALT-like lesion formation in the lungs of SE2(-/-) mice was also associated with a significant increase in the activation of thrombin, a recognized target of SE2, and excess stimulation of NF-κB, a major regulator of chemokine expression and inflammation. Finally, systemic delivery of thrombin rapidly stimulated lung chemokine expression in vivo These data uncover a novel mechanism whereby loss of serine protease inhibition leads to lung lymphocyte accumulation.-Solleti, S. K., Srisuma, S., Bhattacharya, S., Rangel-Moreno, J., Bijli, K. M., Randall, T. D., Rahman, A., Mariani, T. J. Serpine2 deficiency results in lung lymphocyte accumulation and bronchus-associated lymphoid tissue formation. © FASEB.Entities:
Keywords: chemokines; protease nexin-1; serine protease inhibitor; tertiary lymphoid structures; thrombin
Mesh:
Substances:
Year: 2016 PMID: 27059719 PMCID: PMC6137455 DOI: 10.1096/fj.201500159R
Source DB: PubMed Journal: FASEB J ISSN: 0892-6638 Impact factor: 5.191